SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-102293
Filing Date
2023-09-20
Accepted
2023-09-20 16:05:43
Documents
14
Period of Report
2023-09-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2326470d1_8k.htm   iXBRL 8-K 38042
2 EXHIBIT 5.1 tm2326470d1_ex5-1.htm EX-5.1 19597
6 GRAPHIC tm2326470d1_ex5-1img001.jpg GRAPHIC 8347
  Complete submission text file 0001104659-23-102293.txt   250588

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA elox-20230918.xsd EX-101.SCH 3024
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE elox-20230918_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elox-20230918_pre.xml EX-101.PRE 22365
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2326470d1_8k_htm.xml XML 3230
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31326 | Film No.: 231266563
SIC: 2836 Biological Products, (No Diagnostic Substances)